China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong · Delayed Price · Currency is HKD 8.13
-0.18 (-2.11%)
Sep 18, 2026, 4:08 PM HKT
HKG:2877 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,664 | 3,135 | 3,778 | 4,517 | 3,951 | 3,224 |
Revenue Growth | -15.04% | -17.01% | -16.35% | 14.32% | 22.55% | 21.38% |
Gross Profit Gross Profit Growth | 1,898 | 2,266 | 2,832 | 3,394 | 2,938 | 2,410 |
Operating Income Operating Income Growth | 650.83 | 682.07 | 835.99 | 970.1 | 713.58 | 534.37 |
Net Income Net Income Growth | 804.44 | 949.95 | 840.05 | 969.51 | 722.77 | 556.67 |
Earnings Per Share EPS Growth | 1.07 | 1.26 | 1.11 | 1.28 | 0.96 | 0.74 |
EPS Growth | -15.20% | 13.29% | -13.51% | 34.14% | 29.79% | 89.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,538 | 7,571 | 6,495 | 5,913 | 5,050 | 4,210 |
Total Debt Total Debt Growth | 312.29 | 334.9 | 346.53 | 301.33 | 7.44 | 14.91 |
Net Cash (Debt) Net Cash Growth | 7,226 | 7,237 | 6,148 | 5,611 | 5,043 | 4,195 |
Net Cash Growth | -0.14% | 17.70% | 9.56% | 11.28% | 20.21% | 17.97% |
Net Cash Per Share Net Cash Per Share Growth | 9.58 | 9.58 | 8.14 | 7.43 | 6.68 | 5.56 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,172 | 963.14 | 932.64 | 1,110 | 703.15 |
Capital Expenditures CapEx Growth | - | -197.91 | -140.11 | -144.33 | -129.46 | -93.63 |
Free Cash Flow Free Cash Flow Growth | - | 974.13 | 823.02 | 788.31 | 980.21 | 609.52 |
Free Cash Flow Growth | - | 18.36% | 4.40% | -19.58% | 60.82% | 6.46% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.26% | 72.28% | 74.95% | 75.15% | 74.38% | 74.77% |
Operating Margin | 24.43% | 21.75% | 22.13% | 21.48% | 18.06% | 16.58% |
Pretax Margin | 39.90% | 40.48% | 30.33% | 27.46% | 23.21% | 22.34% |
Profit Margin | 30.20% | 30.30% | 22.23% | 21.47% | 18.30% | 17.27% |
FCF Margin | - | 31.07% | 21.78% | 17.45% | 24.81% | 18.91% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.550 | 0.470 | 0.540 | 0.420 | 0.320 | 0.390 |
Dividend Per Share Growth | 378.22% | -12.96% | 28.57% | 31.25% | -17.95% | 21.88% |
Dividend Yield | 6.77% | 7.20% | 7.53% | 8.58% | 6.81% | 10.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.60 | 6.15 | 8.15 | 5.14 | 7.02 | 7.62 |
Forward PE | 6.94 | 7.00 | 6.29 | 5.10 | 7.57 | 6.45 |
P/FCF Ratio | - | 5.99 | 8.32 | 6.32 | 5.17 | 6.96 |
PS Ratio | 2.00 | 1.86 | 1.81 | 1.10 | 1.28 | 1.32 |